The general consensus from these studies is that ACTN3 genotype exhibits a potentially modifying effect on muscle mass, maintenance of muscle function, and sarcopenia risk in elderly subjects, with the R allele associated with greater maintenance of strength and function, and sarcopenia protection. Here, ACTN3 is linked to sarcopenia.